Humacyte, Inc. (HUMA) short interest & options flow
NASDAQHumacyte, Inc. heads into its Q1 2026 earnings release tomorrow with short sellers dug in at levels that leave little margin for disappointment — and a borrow market that has tightened sharply over the past month. Short interest is running at roughly 24% of the free float, with days to cover above 12. That is a heavily shorted position by any measure. What makes it notable is how…
- Market cap
- $167M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026

HUMA news and analysis
RSSNo long-form analysis yet for HUMA. Pulse alerts and the live data picture are available on ORTEX.
Open HUMA on ORTEX →Want the live picture for HUMA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HUMA — free to start on ORTEX.
Sign up for free →Open HUMA on ORTEX